Publication & Citation Trends
Publications
0 total
CTIM-22. MEDIAN AND 2 YEARS SURVIVAL OF NEWLY DIAGNOSED UNMETHYLATED MGMT GLIOBLASTOMA PATIENTS TREATED WITH TEMFERON IMMUNO-GENE THERAPY
Cited by 0
Semantic Scholar
Abstract 5213: Genetically modified Tie-2 expressing monocytes target IFN-α2 to the glioblastoma tumor microenvironment (TME): Preliminary data from the TEM-GBM Phase 1/2a study
Cited by 0
Semantic Scholar
Reprogramming Macrophages Using Autologous Hematopoietic Stem Cells As Immunotherapy for Glioblastoma: TEM-GBM Study (NCT03866109) OA
Cited by 0
Semantic Scholar
648 Autologous macrophage-based immunotherapy Induces a pro-inflammatory state in GBM tumor microenvironment – (TEM-GBM) OA
Cited by 0
Semantic Scholar
379TiP TEM-GBM: A phase I-IIa clinical study of genetically modified Tie-2-expressing monocytes in patients with glioblastoma multiforme OA
Cited by 1
Semantic Scholar
Abstract CT180: Changes in immunologic responses and in the tumor microenvironment in patients with glioblastoma multiforme treated with IFN-a immune cell and gene therapy (TEM-GBM_001 Study)
Cited by 0
Semantic Scholar
A phase I-IIa study of genetically modified Tie-2 expressing monocytes in patients with glioblastoma multiforme (TEM-GBM Study).
Cited by 11
Semantic Scholar
TEM-GBM: An Open-Label, Phase I/IIa Dose-Escalation Study Evaluating the Safety and Efficacy of Genetically Modified Tie-2 Expressing Monocytes to Deliver IFN-α within Glioblastoma Tumor Microenvironment OA
Cited by 2
Semantic Scholar
Research Topics
Glioma Diagnosis and Treatment
(20)
Immune cells in cancer
(12)
Extracellular vesicles in disease
(11)
Meningioma and schwannoma management
(7)
Advanced MRI Techniques and Applications
(5)
Affiliations
University of Trieste
Johns Hopkins University
University of Milan
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Austrian Center for Medical Innovation and Technology